blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2107912

EP2107912 - OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING FORMS OF VITAMIN B [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  25.10.2019
Database last updated on 24.08.2024
Most recent event   Tooltip25.10.2019Refusal of applicationpublished on 27.11.2019  [2019/48]
Applicant(s)For all designated states
FXS Ventures, LLC
22 Fox Run Lane
Salem, NH 03079 / US
[2009/42]
Inventor(s)01 / SMITH, Francis, X.
22 Fox Run Lane
Salem, NH 03079 / US
 [2009/42]
Representative(s)Wagner, Karl H., et al
Wagner & Geyer Partnerschaft mbB
Patent- und Rechtsanwälte
Gewürzmühlstrasse 5
80538 München / DE
[N/P]
Former [2009/42]Wagner, Karl H.
Wagner & Geyer Gewürzmühlstrasse 5
80538 Munich / DE
Application number, filing date08713604.007.01.2008
[2009/42]
WO2008US50375
Priority number, dateUS2007062031805.01.2007         Original published format: US 620318
[2009/42]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008086270
Date:17.07.2008
Language:EN
[2008/29]
Type: A2 Application without search report 
No.:EP2107912
Date:14.10.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 17.07.2008 takes the place of the publication of the European patent application.
[2009/42]
Search report(s)International search report - published on:EP27.08.2009
ClassificationIPC:A61L12/14, C11D3/00, C11D3/32, C11D3/33, C11D3/34, C11D3/37
[2009/42]
CPC:
A61L12/142 (EP,US); A61L12/145 (EP,US); C11D3/0078 (EP,US);
C11D3/168 (EP,US); C11D3/28 (EP,US); C11D3/30 (EP,US);
C11D3/32 (EP,US); C11D3/323 (EP,US); C11D3/33 (EP,US);
C11D3/3481 (EP,US); C11D3/362 (EP,US); C11D3/3703 (EP,US);
C11D3/48 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2009/42]
TitleGerman:LÖSUNGEN FÜR OPHTHALMISCHE LINSEN UND KONTAKTLINSEN MIT FORMEN VON VITAMIN B[2009/42]
English:OPHTHALMIC AND CONTACT LENS SOLUTIONS CONTAINING FORMS OF VITAMIN B[2009/42]
French:SOLUTIONS OPHTALMIQUES ET POUR LENTILLES DE CONTACT CONTENANT DES FORMES DE VITAMINE B[2009/42]
Entry into regional phase03.07.2009National basic fee paid 
03.07.2009Designation fee(s) paid 
03.07.2009Examination fee paid 
Examination procedure03.07.2009Amendment by applicant (claims and/or description)
03.07.2009Examination requested  [2009/42]
18.11.2010Despatch of a communication from the examining division (Time limit: M06)
01.07.2011Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
09.09.2011Reply to a communication from the examining division
10.09.2014Despatch of a communication from the examining division (Time limit: M04)
20.01.2015Reply to a communication from the examining division
13.03.2017Date of oral proceedings
05.04.2017Despatch of communication that the application is refused, reason: substantive examination [2019/48]
05.04.2017Minutes of oral proceedings despatched
10.10.2019Application refused, date of legal effect [2019/48]
Appeal following examination02.06.2017Appeal received No.  T2000/17
07.08.2017Statement of grounds filed
10.10.2019Result of appeal procedure: appeal of the applicant withdrawn
Divisional application(s)EP12007768.0  / EP2561894
EP12007769.8  / EP2561895
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  18.11.2010
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the examination report
09.09.2011Request for further processing filed
09.09.2011Full payment received (date of receipt of payment)
Request granted
30.09.2011Decision despatched
Fees paidRenewal fee
25.01.2010Renewal fee patent year 03
25.01.2011Renewal fee patent year 04
25.01.2012Renewal fee patent year 05
25.01.2013Renewal fee patent year 06
27.01.2014Renewal fee patent year 07
27.01.2015Renewal fee patent year 08
27.01.2016Renewal fee patent year 09
27.01.2017Renewal fee patent year 10
29.01.2018Renewal fee patent year 11
28.01.2019Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[Y]GB1431841  (EVANS S C) [Y] 12,13 * page 2, lines 30-76; claim 1 *;
 [X]WO9304706  (ALLERGAN INC [US]) [X] 12,13 * page 6, lines 7-30 * * page 10, line 16 - page 11, line 35 * * examples 1-3 * * claims 7,19 *;
 [X]JPH08152584  (ASAHI CHEMICAL IND) [X] 12,13 * abstract *;
 [X]WO0238161  (BIO CONCEPT LAB [US], et al) [X] 12,13 * page 1 - page 2; claim - *;
 [XY]WO02062260  (BIO CONCEPT LAB [US], et al) [X] 1-14 * claims 1-7 * * page 3 - page 6 * [Y] 1-14;
 [X]US2003190258  (SMITH FRANCIS X [US]) [X] 12,13 * page 5 - page 6; examples 8-10 *;
 [XY]JP2006089403  (FUJITA HIRONORI, et al) [X] 12,13 * see also English automatic translation from JPO website: http://dossier1.ipdl.inpit.go.jp; paragraphs [0040] - [0042]; examples 7,8 * [Y] 1-14;
 [XY]US2006148665  (SMITH FRANCIS X [US]) [X] 1-14 * page 1, paragraphs 6,7 * * page 1, paragraph 12 - page 2, paragraph 19 * * claims 1-7 * [Y] 1-14;
 [PX]US2007104744  (SMITH FRANCIS X [US]) [PX] 1-14 * page 1, paragraph 13 - page 2, paragraph 21 * * claims 1-12 *;
 [E]WO2008077110  (FXS VENTURES LLC [US], et al) [E] 1-14 * page 2, paragraphs 6,7 * * page 4, paragraphs 15-19 ** claims 1-14 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.